Other Streetwise ReportsThe Gold Report The Energy Report The Life Sciences Report The Mining Report
Today's Featured Company
Celator Pharmaceuticals Inc.: (CPXX:NASDAQ) Celator Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve patient outcomes in cancer. The company's proprietary technology platform, CombiPlex«, enables the rational design and rapid evaluation of optimized combinations, incorporating traditional chemotherapies and molecularly targeted agents to deliver enhanced anticancer activity. Moreá>
Streetwise Expert Interviews
Biotech investors are abuzz over immune checkpoint inhibitors and T-cell therapies, but which ones do you pick? JonesTrading Institutional Services Senior Equity Analyst George Zavoico is moving rapidly to initiate coverage on some key names in this space, and is casting a wide net in hopes of catching winners. In this interview with The Life Sciences Report, Zavoico delineates some movers and shakers in the cancer immunotherapy field, and recommends investors keep their pencils sharp and eyes open as data emerge over the next year or two.(6/24/15) More >
Joseph Pantginis of ROTH Capital Partners recognizes the characteristics that make micro-cap biotech companies move up the ladder in market valuation, and discusses five names with development programs capable of generating dramatic growth. (6/17/15) More >
Learn More About Companies in This Issue
|Alliance for Regenerative Medicine|
BrainStorm Cell Therapeutics Inc.
RepliCel Life Sciences Inc.
|Nobilis Health Corp.|